Found: 26
Select item for more details and to access through your institution.
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 2, p. 619, doi. 10.1007/s00432-020-03365-w
- By:
- Publication type:
- Article
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00966-9
- By:
- Publication type:
- Article
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00966-9
- By:
- Publication type:
- Article
Idiopathic giant abdominal lymph cyst: a case report.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 991, doi. 10.1111/bjh.13830
- By:
- Publication type:
- Article
Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074191
- By:
- Publication type:
- Article
Multi‐subgroup gene screening using semi‐parametric hierarchical mixture models and the optimal discovery procedure: Application to a randomized clinical trial in multiple myeloma.
- Published in:
- Biometrics, 2018, v. 74, n. 1, p. 313, doi. 10.1111/biom.12716
- By:
- Publication type:
- Article
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1065, doi. 10.1007/s00277-021-04405-2
- By:
- Publication type:
- Article
Enhancing cancer clonality analysis with integrative genomics.
- Published in:
- BMC Bioinformatics, 2015, v. 16, p. 1, doi. 10.1186/1471-2105-16-S13-S7
- By:
- Publication type:
- Article
Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing.
- Published in:
- BMC Bioinformatics, 2014, v. 15, n. Suppl 11, p. 1, doi. 10.1186/1471-2105-15-S11-S3
- By:
- Publication type:
- Article
Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis.
- Published in:
- BMC Bioinformatics, 2014, v. 15, n. Suppl 11, p. 1, doi. 10.1186/1471-2105-15-S11-S9
- By:
- Publication type:
- Article
Towards the integration, annotation and association of historical microarray experiments with RNA-seq.
- Published in:
- BMC Bioinformatics, 2013, v. 14, n. Suppl 14, p. 1, doi. 10.1186/1471-2105-14-S14-S4
- By:
- Publication type:
- Article
Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Translating a gene expression signature for multiple Myeloma prognosis into a robust high-throughput assay for clinical use.
- Published in:
- BMC Medical Genomics, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1755-8794-7-25
- By:
- Publication type:
- Article
Nasopharyngeal amyloidoma with osteolytic lesions leading to diagnosis of systemic light-chain amyloidosis.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 6, p. 812, doi. 10.1002/ccr3.922
- By:
- Publication type:
- Article
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 665, doi. 10.1016/j.clml.2024.05.003
- By:
- Publication type:
- Article
Greater Treatment Satisfaction in Patients Receiving Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) for Relapsed or Refractory Multiple Myeloma (RRMM): COLUMBA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e247, doi. 10.1016/j.clml.2019.09.410
- By:
- Publication type:
- Article
In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
- Published in:
- Genes, Chromosomes & Cancer, 2014, v. 53, n. 7, p. 549, doi. 10.1002/gcc.22165
- By:
- Publication type:
- Article
Mechanism of action of lenalidomide in hematological malignancies.
- Published in:
- Journal of Hematology & Oncology, 2009, v. 2, p. 1, doi. 10.1186/1756-8722-2-36
- By:
- Publication type:
- Article
Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 5, p. 614, doi. 10.1002/jcph.1771
- By:
- Publication type:
- Article
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 2, p. 1328, doi. 10.1007/s12325-020-01601-w
- By:
- Publication type:
- Article
Results of a Time and Motion Survey Regarding Subcutaneous versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma.
- Published in:
- ClinicoEconomics & Outcomes Research, 2021, v. 13, p. 465, doi. 10.2147/CEOR.S302682
- By:
- Publication type:
- Article
Induction, binding specificity and function of human ICOS.
- Published in:
- European Journal of Immunology, 2000, v. 30, n. 12, p. 3707, doi. 10.1002/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO;2-Q
- By:
- Publication type:
- Article
Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand.
- Published in:
- European Journal of Immunology, 2000, v. 30, n. 4, p. 1040, doi. 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6
- By:
- Publication type:
- Article